SC
BIO icon

Skylands Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Skylands Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Buy
5,650
+2,050
+57% +$590K 0.21% 90
2025
Q4 		$1.09M Buy
3,600
+550
+18% +$172K 0.15% 98
2025
Q3 		$855K Sell
3,050
-950
-24% -$259K 0.12% 106
2025
Q2 		$965K Buy
4,000
+3,500
+700% +$827K 0.14% 107
2025
Q1 		$122K Buy
+500
New +$150K 0.02% 145
2024
Q4 		– Sell
-1,500
Closed -$502K – 152
2024
Q3 		$502K Buy
1,500
+100
+7% +$31.8K 0.07% 121
2024
Q2 		$382K Buy
1,400
+500
+56% +$145K 0.05% 121
2024
Q1 		$311K Sell
900
-1,250
-58% -$411K 0.04% 127
2023
Q4 		$694K Buy
+2,150
New +$674K 0.1% 104

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return